Monash IVF GroupASX:MVF 76 FCF Yield % is 3.63 as of Jun. 27, 2026, which is 48% below its 10-year median of 7.01. GuruFocus rates ASX:MVF with a GF Score™ of 76/100 and a GF Value™ of A$1.39 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, Monash IVF Group ranks better than 74.42% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Monash IVF Group's FCF Yield % or its related term are showing as below:
ASX:MVF'
s FCF Yield % Range Over the Past 10 Years
Min: -0.64 Med: 7.01 Max: 27.16
Current: 3.63
During the past 12 years, the highest FCF Yield % of Monash IVF Group was 27.16%. The lowest was -0.64%. And the median was 7.01%.
ASX:MVF's FCF Yield % is ranked better than 74.42% of 215
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.41
vs ASX:MVF: 3.63
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Monash IVF Group FCF Yield % Related Terms
Monash IVF Group FCF Yield % Historical Data
* Premium members only.
The historical data trend for Monash IVF Group's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Monash IVF Group's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Monash IVF Group FCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Monash IVF Group's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Monash IVF Group's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Monash IVF Group (ASX:MVF) has a FCF Yield % of 3.63 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Monash IVF Group and its competitors. This is 48% below median its historical median of 7.01. According to the industry distribution chart, Monash IVF Group ranks #55 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 25.6%.
Is Monash IVF Group's FCF Yield % too high?
Monash IVF Group's current FCF Yield % of 3.63 is 48% below median its 10-year median of 7.01. Based on the distribution chart, Monash IVF Group ranks #55 out of 215 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Monash IVF Group has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Monash IVF Group's FCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Monash IVF Group ranks #55 out of 215 companies for FCF Yield %. This puts Monash IVF Group in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Diagnostics & Research company?
A good FCF Yield % depends on the Medical Diagnostics & Research industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Monash IVF Group and its competitors. Monash IVF Group's current FCF Yield % is 3.63, which is 48% below median its own 10-year median of 7.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monash IVF Group stock overvalued right now?
Based on GuruFocus' analysis, Monash IVF Group (ASX:MVF) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.39, compared to a current price of A$0.71 — trading 48.9% below its estimated fair value. The current FCF Yield % is 3.63, which is 48% below median its 10-year median of 7.01. Monash IVF Group's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Monash IVF Group (ASX:MVF), the current FCF Yield % is 3.63 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Monash IVF Group (ASX:MVF) Overvalued in 2026?
Based on GuruFocus' analysis, Monash IVF Group stock appears to be undervalued.
The current stock price of A$0.71 is trading 48.9% below its estimated GF Value™ of A$1.39.
GuruFocus considers Monash IVF Group to be Possible Value Trap.
Key valuation signals for ASX:MVF:
FCF Yield %: 3.63 (48% below median its 10-year median of 7.01)
GF Value™: A$1.39 vs. price of A$0.71 (48.9% below fair value)
No single metric tells the full story. See the ASX:MVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Monash IVF Group Ltd is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates two main segments: Australia IVF and Ultrasound, which offer ARS, ultrasound, and related women's health services, and International IVF, which provides assisted reproductive care in South East Asia. The majority of revenue is generated from the Australian segment through its brands such as Fertility Solutions, KL Fertility, Monash IVF, Repromed, and others.
76GF Score
Get the complete analysis for ASX:MVF
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:MVF has been successfully added to your 
